[Funding alert] Berlin-based Yendou Raises €1.2 Million in Pre-Seed Funding

Yendou has quickly gained the interest and adoption of more than 1,200 clinicians across 46 countries since its inception in March 2023. This demand highlights the platform's effectiveness and appeal on a worldwide scale.

Read also - London-based KLIQ Secures €1.4 Million in Pre-Seed Funding

Yendou CEO and co-founder Zina Sarif said, “We like to think of ourselves as Salesforce for R&D teams in life sciences, offering a unique value proposition by providing a curated pool of qualified clinical leads at their fingertips,” “We are creating a knowledge automation platform for clinical researchers to eliminate repetitive work, empowering teams to consolidate information and accelerate the pace of clinical trials delivery to clinics.”

Zina Sarif holds a PhD in biochemistry and has worked as a clinical researcher in oncology at the massive pharmaceutical company AstraZeneca. The Yendou team, along with her co-founder Patrick Rogg, a software engineer with prior expertise at Citadel and Amazon Web Services, has developed a system that thoroughly understands the issues surrounding clinical trials.

Treatable diseases claim the lives of 41 million people annually. Typically, it takes 12 years and $2 billion on average to get a novel medication to the market. A third of the time needed to complete a clinical study is related to the selection of the clinical locations alone.

Many pharmaceutical businesses still collect and handle clinical data using spreadsheets and other software programmes, which are largely manual operations. The inability of these instruments to communicate with each other seamlessly is a serious problem.

Johanna Junkermann, Investment Manager at venture capital firm b2venture said, “We were impressed by the entire Yendou team and their ability to immediately generate market traction, Her deep understanding of the problem, coupled with an extensive network in the industry, positions her and her team uniquely to lead the charge in creating a category-defining product for the pharmaceutical and biotech industries.”

About Yendou

Yendou is a cutting-edge platform for workflow automation and data management. Their goal is to create and invent cutting-edge technologies that enable Life Sciences businesses to provide patients around the world with life-saving treatments more quickly.

Read also - Manchester-based ESProfiler Secures £2.8 Million in Seed Funding